This inventor holds 1 USPTO granted patent. Top assignee: Rutgers, The State University of New Jersey. Active years: 2003.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2003
Title: Mohammed Rafi: Innovator in Cancer Treatment
Introduction
Mohammed Rafi is a notable inventor based in Highland Park, NJ (US). He has made significant contributions to the field of cancer treatment through his innovative research and patented inventions. His work focuses on utilizing specific compounds to induce cell apoptosis, which is crucial in combating cancer.
Latest Patents
Rafi holds a patent for a method involving 1-O-acetylbritannilactone and 1,6-O,O-diacetylbritannilactone. This patent outlines compositions and methods for preventing and treating cancer. The compounds are isolated and used to induce apoptosis in cells, which is essential for effective cancer treatment. The patent emphasizes the importance of Bcl-2 protein phosphorylation in the treatment process.
Career Highlights
Rafi is affiliated with Rutgers, the State University of New Jersey, where he conducts his research. His work has garnered attention for its potential impact on cancer therapies. The innovative approaches he has developed are paving the way for new treatment options.
Collaborations
Rafi has collaborated with esteemed colleagues such as Chi-Tang Ho and Robert S Dipaola. These partnerships enhance the research and development of effective cancer treatments.
Conclusion
Mohammed Rafi's contributions to cancer treatment through his patented inventions highlight his role as an innovator in the field. His work continues to inspire advancements in medical research and therapy.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile